# LH-001 vs Placebo in Healthy Participants

> **NCT06546449** · PHASE1 · SUSPENDED · sponsor: **Chien-Liang Lin** · enrollment: 56 (estimated)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** LH-001
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT06546449
- **Lead sponsor:** Chien-Liang Lin
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** SUSPENDED
- **Start date:** 2025-05-05
- **Primary completion:** 2027-06
- **Final completion:** 2027-12
- **Target enrollment:** 56 (ESTIMATED)
- **Why stopped:** The NIA discontinued funding for the SAD portion of the trial
- **Last updated:** 2026-04-21

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06546449

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06546449, "LH-001 vs Placebo in Healthy Participants". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT06546449. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*